stock
SCTX · Scribe Therapeutics, Inc.
What Scribe Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live SCTX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on SCTX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 18,931,680 as of 2026-08-31 (XBRL frame CY2026Q3I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- —
- ROA
- —
Health
- Current ratio
- 0.6x
- Debt/equity
- —
Deep value
- NCAV
- -$57.31M
- NCAV per share
- -$3.03
- Price/NCAV
- Locked
- NNWC
- -$66.83M
- NNWC per share
- -$3.53
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $1.92M | —Gross profit: unreported by this company. | -$9.39M | -$6.48M | 10-Q filed 2026-09-02 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | — | -$17.35M | 10-Q filed 2026-09-02 |
| 2025-06-30 | $4.90M | —Gross profit: unreported by this company. | -$11.63M | -$9.90M | 10-Q filed 2026-09-02 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | — | -$3.42M | 10-Q filed 2026-09-02 |
- Assets
- $57.93M
- Equity
- -$164.85M
Balance as of 2026-06-30.
Ten years
No annual results reported by SEC for this filer.
Company filings
1 offering filing in 12 months
5% owners ()
RA Capital Management, L.P.
Passive stake
Avoro Capital Advisors LLC
Activist stake
ELI LILLY & Co
Activist stake
ORBIMED ADVISORS LLC
Activist stake
Insiders, politicians and funds
Insider trades, last 90 days
AH Bio Fund II, L.P.
10% owner
Buy$4,999,995Jul 29, 7:09 PM ET
GORDON CARL L
Director
Buy$15,000,000Jul 29, 6:50 PM ET
ORBIMED ADVISORS LLC
Director
Buy$15,000,000Jul 29, 6:47 PM ET
Aghazadeh Behzad
Director, 10% owner
Buy$36,259,761Jul 28, 9:30 PM ET
Lucas Svetlana
Chief Business Officer
Buy$45,000Jul 27, 9:42 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named SCTX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about SCTX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on SCTX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the SCTX board